Stock ACUC ACUCORT AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials AcuCort AB

Equities

ACUC

SE0009695927

Drug Retailers

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.52 SEK -3.70% Intraday chart for AcuCort AB -3.70% +25.30%
Apr. 26 AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 AcuCort AB Provides Update on Phase IV Study ZEQ001 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 63.3 21.65 100.3 90.72 60.22 12.98
Enterprise Value (EV) 1 52.89 -12.39 76.36 54.87 43.04 -6.262
P/E ratio -10.3 x -5.14 x -12.8 x -5 x -4.1 x -0.94 x
Yield - - - - - -
Capitalization / Revenue - - 65,675,806 x 26,199,304 x 11,988,266 x 1,969,335 x
EV / Revenue - - 49,985,950 x 15,845,247 x 8,567,999 x -949,961 x
EV / EBITDA - - - - - -
EV / FCF - - - -5,859,350 x -3,270,884 x 726,161 x
FCF Yield - - - -0% -0% 0%
Price to Book 1.83 x 0.8 x 2.17 x 1.5 x 1.32 x 0.73 x
Nbr of stocks (in thousands) 9,798 9,798 19,597 31,282 31,282 31,282
Reference price 2 6.460 2.210 5.120 2.900 1.925 0.4150
Announcement Date 4/4/19 4/17/20 4/6/21 4/12/22 4/14/23 4/17/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - 1.528 3.463 5.023 6.592
EBITDA - - - - - -
EBIT 1 -6.221 -8.37 -7.749 -11.3 -14.82 -13.25
Operating Margin - - -507.22% -326.22% -295.14% -200.99%
Earnings before Tax (EBT) 1 -6.22 -8.369 -7.766 -11.32 -14.79 -13.69
Net income 1 -6.22 -8.369 -7.766 -11.32 -14.79 -13.69
Net margin - - -508.32% -326.97% -294.43% -207.69%
EPS 2 -0.6300 -0.4300 -0.4000 -0.5800 -0.4700 -0.4400
Free Cash Flow - - - -9.364 -13.16 -8.624
FCF margin - - - -270.43% -261.95% -130.82%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/4/19 4/17/20 4/6/21 4/12/22 4/14/23 4/17/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 10.4 34 24 35.9 17.2 19.2
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - -9.36 -13.2 -8.62
ROE (net income / shareholders' equity) -19.4% -21.1% -15.5% -21.2% -27.9% -29.4%
ROA (Net income/ Total Assets) -11.5% -12.6% -9.38% -12.8% -16.4% -15.3%
Assets 1 54.31 66.62 82.81 88.6 90.1 89.46
Book Value Per Share 2 3.520 2.750 2.360 1.930 1.460 0.5700
Cash Flow per Share 2 1.060 1.740 1.220 1.150 0.5500 0.2300
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 4/4/19 4/17/20 4/6/21 4/12/22 4/14/23 4/17/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
ACUCORT AB Stock AcuCort AB
+25.30% 5.89M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.09% 15.55B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-30.56% 11.21B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.19% 6.23B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.74% 6B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-9.25% 5.89B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+0.88% 4.72B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+53.60% 4.32B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-10.49% 3.77B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-12.53% 3.4B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. ACUC Stock
  4. Financials AcuCort AB